Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Zhengde Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company maintains a strong focus on therapeutic areas such as neurology, cardiovascular health, and anti-infectives, with key products including Gabapentin and various cardiovascular agents. Zhengde operates high-standard manufacturing facilities that comply with international GMP requirements, serving both domestic and global markets. Their business model integrates R&D with chemical synthesis and formulation production to provide cost-effective healthcare solutions. The company is recognized as a significant global supplier of APIs, particularly for central nervous system medications, and has successfully passed inspections by the US FDA and EU GMP authorities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhengde Pharmaceutical.